Other Operating Expenses - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.2 PLN -0.18% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ryvu Therapeutics SA
Other Operating Expenses Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Other Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Other Operating Expenses
zł15.7m
CAGR 3-Years
-10%
CAGR 5-Years
-17%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Other Operating Expenses
-zł1.2m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-15%
M
Medicofarma Biotech SA
WSE:MDB
Other Operating Expenses
-zł264.6k
CAGR 3-Years
35%
CAGR 5-Years
22%
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Other Operating Expenses
-zł7.7m
CAGR 3-Years
-74%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Other Operating Expenses?
Other Operating Expenses
15.7m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Other Operating Expenses amounts to 15.7m PLN.

What is Ryvu Therapeutics SA's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 5Y
-17%

Over the last year, the Other Operating Expenses growth was 41%. The average annual Other Operating Expenses growth rates for Ryvu Therapeutics SA have been -10% over the past three years , -17% over the past five years .

Back to Top